Racial differences in treatment and survival among veterans and non-veterans with stage I NSCLC: An evaluation of Veterans Affairs (VA) and SEER-Medicare populations
Cancer Epidemiology, Biomarkers & Prevention Oct 23, 2019
Williams CD, Alpert N, Redding TS, et al. - Given that Stage I NSCLC is preferably managed surgically with radiation reserved for those not receiving surgery, and lower rates of surgery have been reported among Blacks with Stage I NSCLC vs among Whites in earlier studies, researchers evaluated the links between race, treatment and survival, using logistic regression and Cox proportional hazards models, among black and white men aged ≥ 65 years with stage I NSCLC diagnosed 2001-2009 and selected from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and Veterans Affairs (VA) cancer registry. Findings revealed that the likelihood of receiving surgical treatment was less in Blacks among VA and SEER-Medicare patients. When accounting for treatment, similar survival outcomes were reported among Blacks and Whites.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries